Header Logo

Fadi Chalhoub

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pacemaker, Artificial
3
2023
43
2.350
 Why?
Catheter Ablation
4
2022
145
0.880
 Why?
Syncope, Vasovagal
1
2023
8
0.850
 Why?
High-Frequency Jet Ventilation
1
2022
2
0.780
 Why?
High-Frequency Ventilation
1
2022
5
0.770
 Why?
Atrial Fibrillation
5
2022
805
0.650
 Why?
Patient Discharge
1
2022
490
0.620
 Why?
Cardiac Pacing, Artificial
3
2023
34
0.610
 Why?
Anticoagulants
3
2022
480
0.240
 Why?
Treatment Outcome
5
2022
5281
0.230
 Why?
Hypotension
1
2024
48
0.220
 Why?
Body Surface Potential Mapping
2
2013
4
0.210
 Why?
Equipment Design
2
2022
329
0.210
 Why?
Heart Conduction System
2
2013
50
0.200
 Why?
Equipment Failure
1
2022
63
0.200
 Why?
Tidal Volume
1
2022
37
0.190
 Why?
Hypertension
2
2024
568
0.170
 Why?
Prospective Studies
3
2022
3067
0.150
 Why?
Humans
9
2024
59366
0.150
 Why?
Pandemics
1
2022
616
0.140
 Why?
Thromboembolism
2
2014
69
0.130
 Why?
Middle Aged
6
2024
16310
0.110
 Why?
Thiophenes
1
2014
29
0.110
 Why?
Morpholines
1
2014
86
0.110
 Why?
Cardiac Catheters
1
2012
9
0.100
 Why?
Electrodes, Implanted
1
2012
37
0.100
 Why?
Heart Atria
1
2013
135
0.100
 Why?
beta-Alanine
1
2012
8
0.100
 Why?
Registries
2
2014
799
0.100
 Why?
Aged
4
2022
13405
0.090
 Why?
Benzimidazoles
1
2012
54
0.090
 Why?
Image Enhancement
1
2012
188
0.090
 Why?
Warfarin
1
2012
105
0.090
 Why?
Imaging, Three-Dimensional
1
2013
275
0.090
 Why?
Software
1
2013
366
0.080
 Why?
Algorithms
1
2013
974
0.070
 Why?
Feasibility Studies
3
2014
525
0.070
 Why?
Angiotensinogen
1
2024
3
0.060
 Why?
Antihypertensive Agents
1
2024
162
0.050
 Why?
Double-Blind Method
1
2024
715
0.050
 Why?
Blood Pressure
1
2024
495
0.050
 Why?
RNA Interference
1
2024
590
0.040
 Why?
RNA
1
2024
401
0.040
 Why?
Sensitivity and Specificity
2
2013
1091
0.040
 Why?
Male
5
2024
27742
0.040
 Why?
Reproducibility of Results
2
2013
1559
0.040
 Why?
Female
5
2024
30719
0.040
 Why?
Follow-Up Studies
2
2014
2338
0.040
 Why?
Postoperative Complications
2
2014
1204
0.030
 Why?
Perioperative Period
1
2014
19
0.030
 Why?
Rivaroxaban
1
2014
19
0.030
 Why?
Factor Xa Inhibitors
1
2014
34
0.030
 Why?
Equipment Failure Analysis
1
2012
74
0.030
 Why?
Administration, Oral
1
2014
355
0.030
 Why?
Dose-Response Relationship, Drug
1
2014
805
0.020
 Why?
Dabigatran
1
2012
20
0.020
 Why?
Swine
1
2012
352
0.020
 Why?
Secondary Prevention
1
2012
151
0.020
 Why?
Anti-Arrhythmia Agents
1
2012
96
0.020
 Why?
Perioperative Care
1
2012
76
0.020
 Why?
Hemorrhage
1
2012
260
0.020
 Why?
Sex Factors
1
2012
935
0.020
 Why?
Electrocardiography
1
2012
521
0.020
 Why?
Echocardiography
1
2012
457
0.020
 Why?
Incidence
1
2012
1238
0.020
 Why?
Age Factors
1
2012
1504
0.020
 Why?
Adult
1
2024
15679
0.020
 Why?
Retrospective Studies
1
2012
6069
0.010
 Why?
Animals
1
2012
19649
0.010
 Why?
Chalhoub's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_